Cargando…

Fibroblast Growth Factor-23—A Potential Uremic Toxin

Fibroblast growth factor-23 (FGF23) is a circulating member of the FGF family produced mainly by the osteocytes and osteoblasts that can act as a hormone. The main action of FGF23 is to lower phosphatemia via the reduction of urinary phosphate reabsorption and the decrease of 1,25(OH)(2)-D generatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuczera, Piotr, Adamczak, Marcin, Wiecek, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198563/ https://www.ncbi.nlm.nih.gov/pubmed/27941640 http://dx.doi.org/10.3390/toxins8120369

Ejemplares similares

Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
por: Kuczera, Piotr, et al.
Publicado: (2016)

Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
por: Law, Jonathan P., et al.
Publicado: (2020)

Intravenous Phosphate Loading Increases Fibroblast Growth Factor 23 in Uremic Rats
por: Arai-Nunota, Noriko, et al.
Publicado: (2014)

Correction to: Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
Publicado: (2020)

Is inflammation a new risk factor of depression in haemodialysis patients?
por: Nowak, Łukasz, et al.
Publicado: (2012)

Clostridioides difficile Infection in Chronic Kidney Disease—An Overview for Clinicians
por: Dudzicz, Sylwia, et al.
Publicado: (2021)

Clostridioides difficile Infection in Patients after Organ Transplantation—A Narrative Overview
por: Dudzicz-Gojowy, Sylwia, et al.
Publicado: (2022)

Uremic Toxins and Vascular Dysfunction
por: Six, Isabelle, et al.
Publicado: (2020)

Hyponatremia in patients with arterial hypertension: pathophysiology and management
por: Adamczak, Marcin, et al.
Publicado: (2023)

Parathyroid Hormone: A Uremic Toxin
por: Duque, Eduardo J., et al.
Publicado: (2020)

Interaction of Human Serum Albumin with Uremic Toxins: The Need of New Strategies Aiming at Uremic Toxins Removal
por: Zare, Fahimeh, et al.
Publicado: (2022)

Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins
por: Chao, Chia-Ter, et al.
Publicado: (2020)

Uremic Toxin Clearance and Cardiovascular Toxicities
por: Mair, Robert D., et al.
Publicado: (2018)

The Serum Level of Fibroblast Growth Factor-23 and Calcium-Phosphate Homeostasis in Obese Perimenopausal Women
por: Holecki, M., et al.
Publicado: (2011)

Fibroblast growth factor 23 and bone mineralisation
por: Guo, Yu-Chen, et al.
Publicado: (2015)

The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
por: Heijboer, Annemieke C., et al.
Publicado: (2022)

The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders
por: Assem, Maryam, et al.
Publicado: (2018)

Gut-Derived Protein-Bound Uremic Toxins
por: Graboski, Amanda L., et al.
Publicado: (2020)

How do Uremic Toxins Affect the Endothelium?
por: da Cunha, Regiane Stafim, et al.
Publicado: (2020)

The Impact of CKD on Uremic Toxins and Gut Microbiota
por: Rysz, Jacek, et al.
Publicado: (2021)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney Disease
por: Hung, Kuo-Chin, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

Mitochondria as a Source and a Target for Uremic Toxins
por: Popkov, Vasily A., et al.
Publicado: (2019)

The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
por: Czaya, Brian, et al.
Publicado: (2019)

Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
por: Lekawanvijit, Suree
Publicado: (2018)

Uremic Toxins in Organ Crosstalk
por: Lowenstein, Jerome, et al.
Publicado: (2021)

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
por: Liabeuf, Sophie, et al.
Publicado: (2018)

Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction
por: Fujii, Hideki, et al.
Publicado: (2018)

Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications
por: Yamagami, Fumi, et al.
Publicado: (2019)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Role of Uremic Toxins in Early Vascular Ageing and Calcification
por: Kyriakidis, Nikolaos C., et al.
Publicado: (2021)

Food-Derived Uremic Toxins in Chronic Kidney Disease
por: Lauriola, Mara, et al.
Publicado: (2023)

Protein-Bound Uremic Toxins in Senescence and Kidney Fibrosis
por: Yang, Yi, et al.
Publicado: (2023)

Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review
por: Holmar, Jana, et al.
Publicado: (2020)

Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins
por: Ciceri, Paola, et al.
Publicado: (2021)

Serum intact fibroblast growth factor 23 in healthy paediatric population
por: Stanczyk, Malgorzata, et al.
Publicado: (2021)

New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
por: Mace, Maria L., et al.
Publicado: (2020)

Cardiovascular Risk Factors in Patients Before and After Successful Liver Transplantation
por: Gojowy, Damian, et al.
Publicado: (2022)

Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins
por: Schupp, Nicole, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_crnu9kro9hndrvml3361eo6tdp